Case Study: Pregnancy and Early-Onset Type 1 Diabetes

Total Page:16

File Type:pdf, Size:1020Kb

Case Study: Pregnancy and Early-Onset Type 1 Diabetes CASE STUDIES Case Study: Pregnancy and Early-Onset Type 1 Diabetes Christian D. Herter, MD, CDE Presentation C.B. received no nutrition informa- Commentary C.B., a 24-year-old woman, came to tion, but her mother taught her carbohy- Patients with type 2 diabetes are almost our clinic for a diabetes consultation drate counting. They were told that always obese (>20% over IBW). As after being referred by her mother, who metformin was the treatment choice but discussed in a previous issue of is one of our regular patients and has would not be started until our office Clinical Diabetes by Hansen et al.,1 type 1 diabetes herself. The older suggested it. obesity and family history of obesity woman’s diagnosis was made else- Besides being 3 weeks late with her are present in virtually all patients with where 7 years before she sought care menstrual period and having some type 2 diabetes. This is perhaps the with our office and had been based on breast tenderness, C.B. had no other most important risk indicator when her lean frame (5% below ideal body symptoms of pregnancy. Her mother considering the diagnosis. Patients with weight [IBW] based on height) at pres- was the only family member with dia- type 2 diabetes not only have a strong entation and relatively normal insulin betes of any type. C.B. and her husband family history of the disease,2 but also sensitivity (insulin requirements have had been trying to conceive for the past frequently have family members with a always been <0.5 U/kg/day). No anti- 3 months. preponderance of macrovascular condi- body studies or C-peptide levels were On exam, C.B. was a pleasant tions. done at the time of diagnosis. young woman with a weight of 67 kg People with type 1 diabetes are not Her daughter, C.B., was diagnosed and a height of 147 cm (IBW = 65 kg, usually obese and typically do not pres- with type 2 diabetes at a community therefore only 3% over IBW). Except ent with a clear family history of the clinic in a rural area near Seattle 3 for mild bilateral thyromegally, her disease. Often, there is weight loss at weeks before her visit with us. The physical exam was normal. Her home diagnosis, which is seldom a feature of diagnosis was based on her lack of blood glucose monitoring data were type 2 diabetes. Insulin sensitivity is ketones at presentation, “low” present- well ordered but revealed chaotic fluc- spared, so small doses of insulin pro- ing blood glucose of 254 mg/dl, and tuations, with several readings above duce potent hypoglycemic results. age at diagnosis. 400 mg/dl in the mornings and below Though not measured in this case, the Oral agents were suggested for 100 mg/dl at midday. Her HbA1c was presence of certain specific antibodies, C.B., but her mother insisted on insulin 9.2% (normal 4.0–6.0 %). A serum such as islet cell antibody (ICA) or therapy. Her primary care provider was pregnancy test was positive. anti–glutamic acid decarboxylase anti- concerned about this, noting that body (anti-GAD64) are common at insulin is rarely the best first-line treat- Questions diagnosis and even diagnostic when ment in patients with type 2 diabetes, 1. How certain is the diagnosis of type 2 hyperglycemia is evident. but prescribed a temporary regimen for diabetes in this patient? C.B. was lean and was aware of no her to use until her appointment with 2. What course of action is indicated in overweight relatives. She and her moth- me. At bedtime, she was told to take patients presenting with hyper- er were the only family members with 2–4 U of NPH, depending on her bed- glycemia when pregnancy is diag- diabetes. Although she did not present time blood glucose level, as obtained nosed? with ketones, this is a notoriously bad with home blood glucose monitoring. 3. How should C.B. be counseled as to diagnostic marker. Patients with type 2 She was also given a sliding scale for her risk of congenital anomalies if diabetes can present with ketones if lispro to be taken before eating, she decides to continue the preg- they have fasted or are seriously ill. depending on her blood glucose read- nancy? Age at diagnosis also is not a reliable ings. If her blood glucose value was 4. What methods should be used to marker for either disease, since both <150 mg/dl, she was instructed to take screen for pregnancy in women with types of diabetes can occur in young or no supplemental lispro. diabetes? older people. Although she had not 22 Volume 19, Number 1, 2001 • CLINICAL DIABETES CASE STUDIES University of Washington Medical Center 1989-94 (N = 192) nant. This should be a part of the 40% interview every time she visits your 35% office. 30% % Spontaneous Abortion 3. All women with diabetes who are of 25% % Birth Defects reproductive age should be counseled 20% before they are pregnant about the 15% need to optimize metabolic control and plan pregnancy and the risks of 10% spontaneous abortion and birth 5% defects associated with poor metabol- 0% ic control. 4. In diabetes, the risks of spontaneous <6% >10% abortion and fetal anomalies are 6.0 to 6.9%7.0 to 7.9%8.0 to 8.9%9.0 to 9.9% directly related to metabolic control Standardized HbA1c at First Prenatal Visit at the time of conception as well as Figure 1. Preliminary data showing a relationship between presenting HbA1c and rate of throughout the pregnancy. Hyper- spontaneous abortion and birth defects in pregnant women with diabetes. Printed with glycemia is most destructive to fetal permission of the investigators. development during the first trimester of gestation. experienced weight loss, her extreme and miscarriage is an important, and sensitivity to insulin did not suggest sometimes grave, necessity. Women REFERENCES type 2 diabetes. Finally, presenting who have had poor preconception con- serum glucose is not always a meaning- trol of their diabetes are at greater risk 1Hansen JR, Fulop MJ, Hunter MK: ful diagnostic test to assist clinicians in of spontaneous miscarriage, and those Type 2 diabetes mellitus in youth: a grow- with sustained hyperglycemia during ing challenge. Clinical Diabetes, 18:52–56, distinguishing between type 1 and type 2000 2 diabetes. the first trimester have a higher rate of 2American Diabetes Association: C.B.’s primary care physician did major malformations.3,4 Brown et al.5 at Report of the Expert Committee on the not know about her plans to conceive a the University of Washington Medical Diagnosis and Classification of Diabetes child. The notion that insulin is not usu- Center have observed specific risk rela- Mellitus (Committee Report). Diabetes Care 23 (Suppl 1):S4–S19, 2000 tionships between presenting HbA 3 ally the best first therapeutic choice in 1c Mimouni F, Tsang RC: Pregnancy out- type 2 diabetes is correct in most cases. level and the risk of poor outcomes. come in insulin-dependent diabetes: tempo- However, none of the available oral Their preliminary unpublished data, ral relationships with metabolic control dur- agents is currently approved for use in presented in Fig. 1 with permission of ing specific pregnancy periods. Am J Perinatol 5:334–38, 1988 pregnancy, so insulin was the only the investigators, graphically illustrate 4 the profound effect of hyperglycemia at Kitzmiller JL, Buchanan TA, Kjos S, option here. Combs CA, Ratner RE: Preconception care When pregnancy is diagnosed dur- the time of conception. for diabetes, congenital malformations, and ing a period of overt hyperglycemia, spontaneous abortions (Technical Review). hospitalization for rapid metabolic cor- Clinical Pearls Diabetes Care 17:1502–1513, 1996 5 rection is suggested to reduce the rate 1. Obesity and family history of type 2 Brown Z, Gabe S, Holing E: Elevated diabetes are present in virtually all glycated hemoglobin at first prenatal visit of spontaneous abortion and fetal predicts increased birth defects and SABs: anomalies. Hospitalization is, therefore, patients with the disease. They are preliminary data from an ongoing study. strongly recommended for all women strong markers. Age, the presence of Department of Obstetrics and Gynecology, who present with hyperglycemia at ketones at diagnosis, and presenting University of Washington Medical Center, diagnosis of pregnancy. Our patient serum glucose are poor indicators. April 2000 was advised to proceed immediately to 2. Every woman with diabetes who is of Christian D. Herter, MD, CDE, is in the regional prenatal center, where she reproductive age must be counseled private practice in Seattle, Wash. He was promptly admitted. about contraception and family plan- also functions as a satellite preceptor Counseling expectant mothers ning and asked if there is even the for the Mayo Medical School in about the risks of fetal malformations slightest chance she could be preg- Rochester, Minn. CLINICAL DIABETES • Volume 19, Number 1, 2001 23 CASE STUDIES Case Study: A 36-Year-Old Woman With Type 2 Diabetes and Pregnancy Diane M. Karl, MD Presentation continued insulin on her own and is already poorly controlled on maximal C.M. is a 36-year-old Spanish-speaking resumed taking glyburide 10 mg twice sulfonylurea treatment suggests a longer Mexican-American woman with a 3- daily. duration of diabetes. This supports the year history of type 2 diabetes. She possibility that her poor obstetrical his- was seen in her primary physician’s Questions tory may have been related to undiag- office because of a missed menstrual 1. Is there a relationship between nosed (and, therefore, uncontrolled) dia- period; a pregnancy test was positive.
Recommended publications
  • Alcohol, Breastfeeding, and Development at 18 Months
    Alcohol, Breastfeeding, and Development at 18 Months Ruth E. Little, ScD*; Kate Northstone, MSc‡; Jean Golding, PhD, ScD‡; and the ALSPAC Study Team‡ ABSTRACT. Objective. We aimed to replicate a pre- literature search, we found only 1 systematic study1 vious study of 1-year-olds that reported a deficit in motor that measured drinking during lactation and subse- development associated with moderate alcohol use dur- quent child development. The authors reported a ing lactation, using a different but comparable popula- decrease in the motor development of infants at 1 tion. year of age, as measured by the Bayley Scales,2 when Methodology. The mental development of 915 18- the lactating mother had as little as 1 drink daily in month-old toddlers from a random sample of a longitu- dinal population-based study in the United Kingdom the first 3 months after delivery. This result was was measured using the Griffiths Developmental Scales. independent of drinking during pregnancy. Frequent self-administered questionnaires during and Lactation is the preferred method of early infant after pregnancy provided maternal data. The dose of feeding, and drinking alcohol is a common social alcohol available to the lactating infant was obtained by custom in most of the western world. Knowing the multiplying the alcohol intake of the mother by the pro- effect on the infant when lactation and alcohol drink- portion of breast milk in the infant’s diet. We compared ing are combined is of high importance, especially in this dose with the Griffiths Scales of Mental Develop- view of the previous report of its adverse effects.
    [Show full text]
  • A Guide to Obstetrical Coding Production of This Document Is Made Possible by Financial Contributions from Health Canada and Provincial and Territorial Governments
    ICD-10-CA | CCI A Guide to Obstetrical Coding Production of this document is made possible by financial contributions from Health Canada and provincial and territorial governments. The views expressed herein do not necessarily represent the views of Health Canada or any provincial or territorial government. Unless otherwise indicated, this product uses data provided by Canada’s provinces and territories. All rights reserved. The contents of this publication may be reproduced unaltered, in whole or in part and by any means, solely for non-commercial purposes, provided that the Canadian Institute for Health Information is properly and fully acknowledged as the copyright owner. Any reproduction or use of this publication or its contents for any commercial purpose requires the prior written authorization of the Canadian Institute for Health Information. Reproduction or use that suggests endorsement by, or affiliation with, the Canadian Institute for Health Information is prohibited. For permission or information, please contact CIHI: Canadian Institute for Health Information 495 Richmond Road, Suite 600 Ottawa, Ontario K2A 4H6 Phone: 613-241-7860 Fax: 613-241-8120 www.cihi.ca [email protected] © 2018 Canadian Institute for Health Information Cette publication est aussi disponible en français sous le titre Guide de codification des données en obstétrique. Table of contents About CIHI ................................................................................................................................. 6 Chapter 1: Introduction ..............................................................................................................
    [Show full text]
  • Dermatology and Pregnancy* Dermatologia E Gestação*
    RevistaN2V80.qxd 06.05.05 11:56 Page 179 179 Artigo de Revisão Dermatologia e gestação* Dermatology and pregnancy* Gilvan Ferreira Alves1 Lucas Souza Carmo Nogueira2 Tatiana Cristina Nogueira Varella3 Resumo: Neste estudo conduz-se uma revisão bibliográfica da literatura sobre dermatologia e gravidez abrangendo o período de 1962 a 2003. O banco de dados do Medline foi consul- tado com referência ao mesmo período. Não se incluiu a colestase intra-hepática da gravidez por não ser ela uma dermatose primária; contudo deve ser feito o diagnóstico diferencial entre suas manifestações na pele e as dermatoses específicas da gravidez. Este apanhado engloba as características clínicas e o prognóstico das alterações fisiológicas da pele durante a gravidez, as dermatoses influenciadas pela gravidez e as dermatoses específi- cas da gravidez. Ao final apresenta-se uma discussão sobre drogas e gravidez Palavras-chave: Dermatologia; Gravidez; Patologia. Abstract: This study is a literature review on dermatology and pregnancy from 1962 to 2003, based on Medline database search. Intrahepatic cholestasis of pregnancy was not included because it is not a primary dermatosis; however, its secondary skin lesions must be differentiated from specific dermatoses of pregnancy. This overview comprises clinical features and prognosis of the physiologic skin changes that occur during pregnancy; dermatoses influenced by pregnancy and the specific dermatoses of pregnancy. A discussion on drugs and pregnancy is presented at the end of this review. Keywords: Dermatology; Pregnancy; Pathology. GRAVIDEZ E PELE INTRODUÇÃO A gravidez representa um período de intensas ções do apetite, náuseas e vômitos, refluxo gastroeso- modificações para a mulher. Praticamente todos os fágico, constipação; e alterações imunológicas varia- sistemas do organismo são afetados, entre eles a pele.
    [Show full text]
  • 14. Management of Diabetes in Pregnancy: Standards of Medical
    Diabetes Care Volume 42, Supplement 1, January 2019 S165 14. Management of Diabetes in American Diabetes Association Pregnancy: Standards of Medical Care in Diabetesd2019 Diabetes Care 2019;42(Suppl. 1):S165–S172 | https://doi.org/10.2337/dc19-S014 14. MANAGEMENT OF DIABETES IN PREGNANCY The American Diabetes Association (ADA) “Standards of Medical Care in Diabetes” includes ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations, please refer to the Standards of Care Introduction. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC. DIABETES IN PREGNANCY The prevalence of diabetes in pregnancy has been increasing in the U.S. The majority is gestational diabetes mellitus (GDM) with the remainder primarily preexisting type 1 diabetes and type 2 diabetes. The rise in GDM and type 2 diabetes in parallel with obesity both in the U.S. and worldwide is of particular concern. Both type 1 diabetes and type 2 diabetes in pregnancy confer significantly greater maternal and fetal risk than GDM, with some differences according to type of diabetes. In general, specific risks of uncontrolled diabetes in pregnancy include spontaneous abortion, fetal anomalies, preeclampsia, fetal demise, macrosomia, neonatal hypoglycemia, and neonatal hyperbilirubinemia, among others.
    [Show full text]
  • 3. Physiologic (Spontaneous) Onset of Labor Versus Scheduled Birth
    3. Physiologic (Spontaneous) Onset of Labor versus Scheduled Birth A new report, Hormonal Physiology of Childbearing: Evidence and Implications for Women, Babies, and Maternity Care (2015), synthesizes an extensive literature about hormonally-driven processes of parturition and the early postpartum period. The following information is drawn from this report. Many women and babies experience scheduled birth – induced labor and/or prelabor cesarean – annually in the United States.1 This fact sheet highlights key benefits of the spontaneous, physiologic onset of labor at term, including fully experiencing beneficial hormonal actions of late pregnancy and early labor, and identifies practices that support hormonal physiology when scheduled birth is medically necessary. Benefits of hormonal preparations of late pregnancy and of physiologic onset of labor Hormonal processes that lead up to the physiologic onset of labor prepare mother and fetus/newborn for upcoming tasks and phases. For example: Increases in oxytocin2 and prostaglandin3 receptors, at the physiologic onset of labor prime the uterus to promote effective contractions in labor. Increases in brain-based (central) receptors for beta-endorphins prepare endogenous pain-relieving pathways (to date, found in animal studies).4 Elevations in mammary and central oxytocin and prolactin receptors prepare for breastfeeding and maternal-infant biological bonding.5 Rising cortisol supports maturation of the fetal lungs and other organs. Prelabor preparations in oxytocin and catecholamine systems promote fetal protective processes in labor and optimal newborn transition.6 Practices that support beneficial hormonal action when scheduled birth is necessary When scheduled birth and other interventions are medically necessary, childbearing women and newborns can benefit from support of physiologic processes as far as safely possible.
    [Show full text]
  • The American Rescue Plan Act's State Option to Extend Postpartum
    The American Rescue Plan Act’s State Option to Extend Postpartum Coverage Authored by Manatt Health April, 2021 Introduction The American Rescue Plan Act of 2021 (ARP) establishes a new state option to extend Medicaid and Children's Health Insurance Program (CHIP) coverage for pregnant women for one year following the baby’s birth.1 Under current law, Medicaid and CHIP pregnant women’s coverage extends only through 60 days postpartum. A woman loses her Medicaid or CHIP coverage at the end of her 60-day postpartum period if she is not eligible for coverage under another Medicaid eligibility category (e.g., the new adult or parent group). ARP’s new state option to extend continuous coverage for one-year postpartum enables states to take a major step towards improving health outcomes for postpartum women and their babies by mitigating coverage loss, providing comprehensive coverage in the postpartum period to address maternal mortality and morbidity, and advancing health equity. There is considerable evidence supporting the policy decision to extend postpartum coverage; about 12 percent of pregnancy-related deaths occur between six weeks and one year postpartum.2 Despite approximately 60 percent of all maternal deaths in the United States (U.S.) being preventable, an estimated 700 women die each year as a result of pregnancy or delivery complications, and women of color are disproportionately affected.3 Black women in 2018, for example, were about 2.5 times more likely to suffer a pregnancy-related death than white women.4 Maternal morbidity in the U.S. has been on the rise since 1993, with women of color similarly experiencing significantly higher rates of severe maternal morbidity than their white counterparts.5 Pregnancy-related complications affecting the mother tend to translate to 1 American Rescue Plan Act of 2021, H.R.1319, § 9812 and § 9822.
    [Show full text]
  • HTSP 101: Everything You Want to Know About Healthy Timing and Spacing of Pregnancy
    HTSP 101: Everything You Want to Know About Healthy Timing and Spacing of Pregnancy Healthy Timing and Spacing of Pregnancy (HTSP) is an intervention to help women and families delay or space their pregnancies to achieve the healthiest outcomes for women, newborns, infants, and children, within the context of free and informed choice, taking into account fertility intentions and desired family size. Background Over the past few years, the United States Agency Qualitative studies conducted by USAID in for International Development (USAID) has Pakistan, India, Bolivia, and Peru showed that sponsored a series of studies on pregnancy spacing women and couples are interested in the healthiest and health outcomes. The research objective was to time to become pregnant versus when to give birth. assess, from the best available evidence, the effects In this way, HTSP differs from previous birth of pregnancy spacing on maternal, newborn and spacing approaches that refer only to the interval child health outcomes. In June 2005, the World after a live birth and when to give birth. HTSP also Health Organization (WHO) convened a panel of 30 provides guidance on the healthiest age for the first technical experts to review six USAID-sponsored pregnancy. studies. Based on their review of the evidence, the technical experts made two recommendations* to the Thus, HTSP encompasses a broader concept of the WHO, which are included in a report and policy reproductive cycle starting from healthiest age for brief1: the first pregnancy in adolescents, to spacing subsequent pregnancies following a live birth, still • After a live birth, the recommended minimum birth, miscarriage or abortion – capturing all interval before attempting the next pregnancy is pregnancy-related intervals in a woman’s at least 24 months in order to reduce the risk of reproductive life.
    [Show full text]
  • Melasma and Endocrine Disorders
    igmentar f P y D l o i a so n r r d Muller and Rees, Pigmentary Disorders 2014, S1 u e r o J s Journal of Pigmentary Disorders DOI: 10.4172/2376-0427.S1-001 ISSN: 2376-0427 Review Article Open Access Melasma and Endocrine Disorders Ilaria Muller* and Aled Rees Centre for Endocrine and Diabetes Sciences, Institute of Molecular & Experimental Medicine, School of Medicine, Cardiff University, UK Abstract Melasma is an acquired and chronic disorder characterized by a localized symmetrical hypermelanosis of the face or, less frequently, involving the neck and forearms. It occurs with a high prevalence during pregnancy, especially during the second half of the gestational period, and in women taking exogenous female hormones. Melasma has also rarely been described in males, especially those affected by primary hypogonadism or taking estrogens for prostatic cancer. Melasma thus appears to be pathologically related to female sex hormones, but this is not consistently reflected in high circulating levels of estrogens or progesterone. This implies that other factors are likely to be relevant, including genetic predisposition, exposure to ultraviolet light, cosmetics and some medications. Melanocortins play a key role in melanogenesis but no cases of melasma have been described in pituitary or adrenal diseases, including those associated with an increase in serum ACTH. An association between melasma and thyroid disorders has been reported only once and not confirmed in subsequent studies. The skin is both a source of, and a target for vitamin D; however, no cases of melasma have been described in association with disordered vitamin D production.
    [Show full text]
  • Exploring the Experiences Related to Postpartum Changes
    Asadi et al. BMC Pregnancy and Childbirth (2021) 21:7 https://doi.org/10.1186/s12884-020-03504-8 RESEARCH ARTICLE Open Access Exploring the experiences related to postpartum changes: perspectives of mothers and healthcare providers in Iran Mahboobeh Asadi1,2, Mahnaz Noroozi3* and Mousa Alavi4 Abstract Background: Numerous changes occur in different aspects of women’s lives in the postpartum period. Women’s adjusting with problems and taking advantage of this opportunity can develop their personality. In this regard, accurate knowledge of their experiences and feelings is necessary to help them to benefit from this period. Therefore, the present study aimed to explore the experiences related to postpartum changes in women. Methods: In the present qualitative study, 23 participants, including women of childbearing age who gave birth and healthcare providers (midwives and obstetricians) in Isfahan, Iran were selected using purposive sampling with a maximum variation strategy. Data were collected through in-depth semi structured interviews, field notes, and daily notes, and simultaneously analyzed using the conventional qualitative content analysis. Results: The data analysis results led to the extraction of three main categories including “feeling of decreased female attractiveness” (with two sub-categories of “ feeling of decreased beauty” and “feeling of decreased sexual function”), “feeling of insolvency and helplessness” (with two sub-categories of “physical burnout”, and “mental preoccupations”) and “beginning a new period in life” (with three sub-categories of “changing the meaning of life”, “feeling of maturity” and “deepening the communication”). Conclusions: Findings of this study can provide a good context for designing interventions to improve the women’s quality of life by explaining and highlighting their experiences in the postpartum period.
    [Show full text]
  • Postpartum Care for the Mother and Newborn
    ABSTRACT This document reports the outcomes of a technical consultation on the full range of issues relevant to the postpartum period for the mother and the newborn. The report takes a comprehensive view of maternal and newborn needs at a time which is decisive for the life and health both of the mother and her newborn. Taking women’s own perceptions of their own needs during this period as its point of departure, the text examines the major maternal and neonatal health challenges, nutrition and breastfeeding, birth spacing, immunization and HIV/AIDS before concluding with a discussion of the crucial elements of care and service provision in the postpartum. The text ends with a series of recommendations for this critical but under-researched and under-served period of the life of the woman and her newborn, together with a classification of common practices in the postpartum into four categories: those which are useful, those which are harmful, those for which insufficient evidence exists and those which are frequently used inappropriately. WHO/RHT/MSM/98.3 Dist.: General Orig.: English CONTENTS Page EXECUTIVE SUMMARY .......................................................................................................1 1 INTRODUCTION .........................................................................................................6 1.1 Preamble ............................................................................................................6 1.2 Background........................................................................................................7
    [Show full text]
  • Gestational Diabetes Mellitus and Obesity Are Related To
    THIEME Original Article 107 Gestational Diabetes Mellitus and Obesity are Related to Persistent Hyperglycemia in the Postpartum Period Diabetes mellitus gestacional e obesidade estão relacionados à hiperglicemia persistente no período pós-parto Patricia Moretti Rehder1 Anderson Borovac-Pinheiro1 Raquel Oliveira Mena Barreto de Araujo1 Juliana Alves Pereira Matiuck Diniz1 Nathalia Lonardoni Crozatti Ferreira1 Ana Claudia Rolim Branco1 Aline de Fatima Dias1 Belmiro Gonçalves Pereira1 1 Obstetrics Departament, Universidade Estadual de Campinas, Address for correspondence Anderson Borovac-Pinheiro, MD, PhD, Campinas, SP, Brazil Cidade Universitária Zeferino Vaz, Barão Geraldo, 13083-970, Campinas, SP, Brazil (e-mail: [email protected]). Rev Bras Ginecol Obstet 2021;43(2):107–112. Abstract Objective To evaluate the obstetric and sociodemographic characteristics of gestational diabetic women who maintained hyperglycemia in the postpartum period (6–12 weeks postpartum). Methods This is a longitudinal cohort study with women who have had gestational diabetes and/or macrosomic children between March 1st, 2016 and March 1st, 2017. Between 6 and 12 weeks after birth, women who had gestational diabetes collected fasting glycemia, glucose tolerance test, and glycated hemoglobin results. The data were collected from medical records and during an interview in the first postpartum consultation. A statistical analysis was performed using frequency, percentage, Chi- Squared test, Fisher exact test, Mann-Whitney test, and multivariate Poisson regres- sion. The significance level adopted for the statistical tests was 5%. Results One hundred and twenty-two women were included. Most of the women were younger than 35 years old (70.5%), white, multiparous, and with no history of gestational diabetes. Thirteen percent of the participants developed persistent Keywords hyperglycemia.
    [Show full text]
  • First Steps Nutrition Modules Module 5 – Nutrition and the Postpartum Period
    First Steps Nutrition Modules Module 5 – Nutrition and the Postpartum Period Introduction The postpartum period is a critical one. Worldwide, most maternal deaths occur during the postpartum period. From a nutrition perspective, this period is critical to the health (and nutritional status) of the mother and infant, and to setting the stage for a healthy feeding relationship. The World Health Organization (WHO) has published guidelines for postpartum care. (WHO, 1998) Many of the guidelines have implications for the nutrition professional, including guidelines for maternal nutrition, including supplementation, general diet, and prevention of micronutrient deficiencies. Guidelines for breastfeeding and infant nutrition are also published, and are covered in Module 7, Breastfeeding Assessment and Support and in Module 6, Nutrition and the Young Infant. Postpartum care should be a collaboration between parents, families, caregivers, health professionals. Essential components of care include promotion of breastfeeding, contraceptive and nutritional advice. (WHO, 1998) In addition to the benefits for the mother, child and family, nutrition intervention between pregnancies may improve the outcome of a subsequent pregnancy. (IOM, 1992) Estimated time to complete this module: 60 minutes. Learning Objectives Participants will be able to: • Describe basic nutrient needs during the normal postpartum period • Identify risk factors during the postpartum period and describe the potential complications and nutritional implications associated with each
    [Show full text]